med-report
Prof. Dr. med. Barbara Tettenborn
Abteilung für Neurophysiologie, Kantonsspital St. Gallen, Switzerland
Pramipexole monotherapy can reduce dyskinesias and delay the need for levodopa treatment in patients with Parkinson's disease
Keywords: Parkinson's disease , dyskinesias, pramipexole
med-congress
| Date | City | Title | CME |
|---|---|---|---|
|
14.05 - 17.05.2008
0710-FC6B |
Grand Saconnex | 16th ECO Congress on Obesity | |
|
15.05 - 18.05.2008
0710-FBAA |
Xiamen | 7th Asian & Oceanian Epilepsy Congress | |
|
15.05 - 17.05.2008
0701-F98C |
Athen | 9th Congress of the European Society for Pediatric Dermatology | |
|
15.05 - 17.05.2008
0805-4003 |
Athen | 9zh Congress of the European Society for Pediatric Dermatology | |
|
15.05 - 17.05.2008
0805-D603 |
Luzern | Fortbildungskurs Dermatologie | |
|
15.05 - 17.05.2008
0802-16AE |
Toledo | 9th European Congress on Telepathology and 3rd International Congress on Virtual Microscopy |
med-drugs
Complete Swiss pharmacopoeia
med-drugs® update 17/08
- Change in indication (6)
- Cymbalta 30 mg, 28 magensaftresiste... Boehringer Ingelheim (Schweiz) GmbH / Eli Lilly
- Cymbalta 60 mg, 14/28/84 magensaftr... Boehringer Ingelheim (Schweiz) GmbH / Eli Lilly
- Cymbalta 30 mg, magensaftresistente... Boehringer Ingelheim (Schweiz) GmbH / Eli Lilly
- New approval (62)
- Abilify 7,5 mg/ml, Injektionslösung... Bristol-Myers Squibb SA
- Betahistin Actavis 16 mg, Tabletten Actavis Switzerland AG
- Betahistin Actavis 16 mg, Tabletten Actavis Switzerland AG
- New Reimbursement (22)
- Avamys, Nasenspray GlaxoSmithKline AG
- Byetta 10 ug, Injektionslösung Eli Lilly (Suisse) SA
- Byetta 5 ug, Injektionslösung Eli Lilly (Suisse) SA





